Journal of Antimicrobial Agents

Antimicrobial peptides represent a fascinating class of molecules that play a crucial role in the innate immune system of various organisms. These peptides exhibit broad-spectrum activity against a wide range of pathogens, including bacteria, viruses, fungi and even some parasites. This article explores the diverse aspects of antimicrobial peptides, covering their structure, mechanisms of action, potential applications and the challenges associated with their utilization. Understanding the intricate world of AMPs is essential for the development of innovative therapeutic strategies in the ongoing battle against infectious diseases.

Antimicrobial resistance poses a significant threat to global public health, rendering once-effective medications ineffective against common infections. Antimicrobial Stewardship Programs have emerged as a critical strategy to address this growing crisis. This article delves into the importance of ASPs, their key components and the role they play in optimizing antimicrobial use. Through a comprehensive exploration of current challenges, successes and future prospects, we highlight the pivotal role that antimicrobial stewardship plays in safeguarding the future of healthcare.

Antimicrobial agents have revolutionized healthcare by combating infectious diseases, yet their widespread use raises concerns about environmental impacts. This article explores the intricate relationship between antimicrobial agents and the environment, shedding light on the consequences of their presence in various ecosystems. It discusses the pathways through which these agents enter the environment, their persistence and potential ecological repercussions. Furthermore, the article explores sustainable practices and regulatory frameworks aimed at mitigating environmental risks while maintaining public health. Striking a balance between human health and ecosystem sustainability is crucial in navigating the complex terrain of antimicrobial usage.

Microorganisms have a ubiquitous distribution and are found in several environments including indoor settings, particularly in household compartments. In different household areas, their prevalence varies depending on different factors. These microorganisms comprise bacteria, fungi, viruses, mites, etc. and are exclusively found in the kitchen, bedroom, washrooms, fans, indoor dust and walls of the house. The current literature indicates the high prevalence of microorganisms in the different parts of indoor environments. The entry of these microbes in the indoor environment follows different channels like air, people, pets, water and growing plants. These microorganisms are also found greatly on culler phones and thus make them a causative tool of various diseases. The value of studying of these microorganisms is more promising if it is known to be a pathogenic species. The informative data were collected from PubMed, ScienceDirect and Google Scholar by searching key terms related to the scope of the review and analyzed carefully. This review aims to summarize the cumulative knowledge about indoor microorganisms and their role in pathogenesis with the hope that everyone should take care of themselves and their environments. The high prevalence of microorganisms in such niches is due to the presence of their ideal growth conditions and mostly transfers to each other by human contact. It is also evident that all types of these indoor microbes have the potential to cause infections and diseases including, asthma, pneumonia and allergy.

Nanotechnology has emerged as a ground-breaking field in the development of antimicrobial agents, revolutionizing our approach to combating microbial infections. This article delves into the recent advances in nanotechnology for antimicrobial applications, exploring the diverse strategies employed to enhance efficacy, reduce resistance and mitigate adverse effects. Key topics include nanomaterials, targeted drug delivery and the potential of nanotechnology to address the global challenge of antimicrobial resistance. As we navigate the intricate landscape of nanotechnology, its integration into antimicrobial therapies holds immense promise for the future of infection control.